Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1

Otto Kauko, Susumu Y. Imanishi, Evgeny Kulesskiy, Laxman Yetukuri, Teemu Daniel Laajala, Mukund Sharma, Karolina Pavic, Anna Aakula, Christian Rupp, Mikael Jumppanen, Pekka Haapaniemi, Luyao Ruan, Bhagwan Yadav, Veronika Suni, Taru Varila, Garry L. Corthals, Jüri Reimand, Krister Wennerberg, Tero Aittokallio, Jukka Westermarck

Journal of Biological Chemistry (2020)

Published on December 3, 2025

DOI: https://doi.org/10.1074/jbc.ra119.011265

← Back to Publications
I. Tamanna et al. • Aug 10, 2026 • Journal of Proteome Research
Abstract Food residues that bypass human digestion are further digested by gut microbes, leading to the production of diverse metabolites,...
J. Grist et al. • May 4, 2026 • Journal of Neuroinflammation
Abstract Given the prevalence of metabolic perturbations in a variety of neurological and neurodegenerative diseases, understanding and monitoring brain metabolism...
M. Gluud et al. • Mar 8, 2026 • Allergy
ABSTRACT Background Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T‐cell lymphoma...